FDA Seizes Elderberry Juice for False Disease Treatment Claims
At the request of the Food and Drug Administration, U.S Marshals seized elderberry juice products that have been distributed by Wyldewood Cellars Inc., based in Kansas, because the products are unapproved and misbranded drugs. According to the FDA’s complaint filed…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
in May 2011, Wyldewood makes claims in violation of the Federal Food, Drug, and Cosmetic Act (FFDCA) that its elderberry juice concentrate cures, treats, or prevents various disease conditions, including AIDS, diabetes and flu. FDA previously issued a warning letter to Wyldewood for violating the FFDCA by promoting and distributing its products as drugs